ECO Animal Health Group plc (AIM:EAH)

Market Cap	56.24M
Revenue (ttm)	79.60M
Net Income (ttm)	1.69M
Shares Out	67.76M
EPS (ttm)	0.02
PE Ratio	34.16
Forward PE	27.70
Dividend	n/a
Ex-Dividend Date	n/a

Volume	118,288
Average Volume	78,648
Open	82.50
Previous Close	83.00
Day's Range	82.25 - 83.10
52-Week Range	50.00 - 100.00
Beta	-0.02
RSI	43.74
Earnings Date	Nov 26, 2025

About ECO Animal Health Group

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infectio...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 224
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: EAH

Financial Performance

In 2024, ECO Animal Health Group's revenue was 79.60 million, a decrease of -10.99% compared to the previous year's 89.42 million. Earnings were 1.69 million, an increase of 60.88%.